HIV Infections Clinical Trials in Newark, New Jersey

3 studies are recruiting for hiv infections in Newark, New Jersey right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Positive Peers Intervention Clinical Trial

    The goal of this clinical trial is to learn if the Positive Peers mobile app intervention increases rates of viral suppression in young (13-34 y/o) persons with HIV. Does use of the Positive Peers app improve viral suppression among young minority persons with HIV? What user characteristics are ass…

    Stage
    Not phased
    Ages
    13 to 34
    Site
    Infectious Disease Practice- Rutgers University, Newark, New Jersey
    Locations
    7 in total
    Run by
    MetroHealth Medical Center

    See if you can join NCT06388109 on ClinicalTrials.gov

  2. A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed

    This study compares the efficacy, safety and tolerability of CAB ULA and RPV ULA administered with CAB long acting (LA) and RPV LA administered in adults and adolescents with HIV who are virologically suppressed on anti-retroviral therapy (ART).

    Stage
    Phase 3
    Ages
    12 and older
    Site
    GSK Investigational Site, Newark, New Jersey
    Locations
    88 in total
    Run by
    ViiV Healthcare

    See if you can join NCT07650916 on ClinicalTrials.gov

  3. A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)

    This clinical study is testing a new medication, VH4524184, to see if it can effectively treat HIV-1 in adults who have never received treatment for their infection. The study is comparing two different doses of VH4524184, each taken with the medications emtricitabine and tenofovir alafenamide (FTC…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    GSK Investigational Site, Newark, New Jersey
    Locations
    123 in total
    Run by
    ViiV Healthcare

    See if you can join NCT07202546 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.